Incheon: Significant Investments in International Biopharma Hub in South Korea
Sartorius' Luc Burgard (from left), Joachim Kreuzburg and René Fáber at the South Korean Ministry of Health and Welfare.
Sartorius is investing around 270 million euros through the end of 2024 in expanding its activities in South Korea. The site in South Korea's major Biotech hub Songdo in Incheon is going to feature cell culture media production, as well as an application center with laboratories and logistics, among other operations.
This article is posted on Sartorius Blog.
The company’s facilities on the property site cover some 25,000 square meters. Sartorius‘ existing activities for service as well as marketing and sales will relocate to the new site under development, which also offers space for further extensions. Construction work at the site is slated to begin in 2022, and production operations are scheduled to start by the end of 2024.
Press Release: Sartorius significantly expands activities in South Korea
Sartorius has been operating a sales and service office in South Korea for more than 30 years. Currently, more than 180 employees work at this location. Sartorius aims to expand further and is now offering a variety of positions in South Korea and throughout Asia. Worldwide, there are over 1,200 open positions waiting for ambitious people.
Career: Join our South Korea Team and Grow With Us
The development of the biopharmaceutical industry in Asia and, in particular, South Korea, has entered a new phase characterized by a high innovation and investment pace on the part of our customers. With our significant investments in Songdo, we will be increasing capacities, moving production operations closer to our customers in the region and substantially accelerating our delivery speed.
Joachim Kreuzburg, Sartorius CEO
Sartorius CEO Joachim Kreuzburg met South Korean Minister of Trade, Industry and Energy, Moon Sung-wook.
Visit at the Ministry of Health and Welfare.
Joachim Kreuzburg and South Korean Minister for Health and Welfare, Kwon Deok-chul.
Rendering of the future Sartorius site in Songdo in Incheon, South Korea.
Sartorius expects continuous strong growth for the current fiscal year and beyond. To support this growth, and to ensure delivery reliability also going forward, we have started to accelerate and extend the expansion of our production capacities very significantly in all geographies, the Americas, Europe, and Asia. By 2025, Sartorius will more than double capacities for key product groups.
Capacity Expansions: Demand for Sartorius Products is Growing Rapidly
